Live Breaking News & Updates on அகலப்படுத்துபவர் பல்கலைக்கழகம் செஸ்டர்

Stay updated with breaking news from அகலப்படுத்துபவர் பல்கலைக்கழகம் செஸ்டர். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Nabriva Therapeutics Appoints Daniel Dolan as Chief Financial Officer


Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Nabriva Therapeutics Appoints Daniel Dolan as Chief Financial Officer
Nabriva Therapeutics US, IncFebruary 26, 2021 GMT
DUBLIN, Ireland and KING OF PRUSSIA, Pa., Feb. 26, 2021 (GLOBE NEWSWIRE) Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infections, today announced the appointment of Daniel Dolan as Chief Financial Officer (CFO), effective close of business March 12, 2021. Mr. Dolan will replace current CFO Gary Sender, who is retiring from Nabriva. Mr. Sender will serve as a consultant for Nabriva at least through the remainder of 2021 to support Mr. Dolan’s transition into the CFO role. ....

United States , Ted Schroeder , Kim Anderson , Mike Beyer , Widener University Chester , Shire Pharmaceuticals , Drug Administration , Merck Co , Takeda Pharmaceutical Company , Sam Brown Inc , Radius Health Inc , Daniel Dolan , Chief Financial Officer , Chief Executive Officer , Radius Health , Widener University , Nabriva Therapeutics , Private Securities Litigation Reform Act , Nabriva Therapeutic , Corporate News , Drug Trials , Products And Services , Health Care Industry , Executive Changes , Clinical Trials , Pharmaceutical Manufacturing ,